Skip to main content
. 2022 Feb 2;9(2):942–946. doi: 10.1002/ehf2.13805

Figure 1.

Figure 1

Forest plot demonstrating clinical outcomes between patients on SGLT2 inhibitors vs. placebo in randomized controlled trials in the setting of heart failure. Square markers represent point estimate of HR for individual studies, with square size representing proportional weight given to each study in the meta‐analysis. Horizontal lines indicate 95% CIs. The solid diamonds represent the estimated 95% CI for effect size of all meta‐analysed data. Abbreviations: CI, confidence interval; CV, cardiovascular; HFH, heart failure hospitalization; HR, hazard ratio; RR, risk ratio; SGLT, sodium glucose cotransporter.